IMPAX LABORATORIES INC's ticker is and the CUSIP is 45256BAE1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $21,492,000 | -2.1% | 70,000 | -16.2% | 0.74% | +245.5% |
| Q4 2017 | $21,958,000 | +172.5% | 83,545 | +232.2% | 0.21% | +255.0% |
| Q3 2017 | $8,059,000 | +15.3% | 25,150 | -8.5% | 0.06% | +13.2% |
| Q2 2017 | $6,989,000 | +75.6% | 27,500 | +38.0% | 0.05% | +29.3% |
| Q1 2017 | $3,979,000 | – | 19,927 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLAZER CAPITAL, LLC | 30,325,000 | $30,211,000 | 3.19% |
| SYMPHONY ASSET MANAGEMENT LLC | 13,716,000 | $13,652,000 | 1.75% |
| Westchester Capital Management, LLC | 22,721,000 | $22,615,000 | 0.88% |
| Lombard Odier Asset Management (Europe) Ltd | 11,860,000 | $11,882,000 | 0.81% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 70,000 | $21,492,000 | 0.74% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 29,500,000 | $29,362,000 | 0.56% |
| Verition Fund Management LLC | 5,350,000 | $5,325,000 | 0.40% |
| AQR Arbitrage LLC | 31,450,000 | $31,303,000 | 0.36% |
| HBK INVESTMENTS L P | 44,871,000 | $44,787,000 | 0.31% |
| SSI INVESTMENT MANAGEMENT LLC | 3,500,000 | $3,466,000 | 0.28% |